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Abstract
Background: Tuberculosis treatment failure and death rates are low in the Western Pacific
Region, including Vietnam. However, failure or death may also occur among patients who did not
complete treatment, i.e. reported as default or transfer-out. We aimed to assess the proportion
failures and deaths among new smear-positive pulmonary tuberculosis patients with reported
default or transfer-out.
Treatment outcomes rates were 1.4% default, 3.0% transfer-out, 0.4% failure and 2.6% death in
northern Vietnam in 2003.
Methods: Tuberculosis patients in 32 randomly selected district tuberculosis units in northern
Vietnam were followed up 1 to 3 years after treatment initiation for survival, recent treatment
history and bacteriologically confirmed tuberculosis.
Results:  Included were 85 transferred patients and 42 who defaulted. No information was
available of 41 (32%), 28 (22%) had died. Fifty-eight were available for follow-up (46%); all had
sputum smear results. Tuberculosis was recorded in 11 (13%), including 6 (7%) with positive
sputum smears, 3 (3%) with negative smears but positive culture and 2 (2%) who had started re-
treatment for bacteriologically confirmed tuberculosis. Fifteen (17%, 95%CI 10–27%) had died
within 8 months after treatment initiation. Of 86 patients with known study outcomes, 39 (45%,
95%CI 35–56%) had died or had bacteriologically confirmed tuberculosis. This was recorded for
29/53 (55%, 95%CI 40–68%) transferred patients and 10/33 (30%, 95%CI 16–49%) patients who
defaulted.
Conclusion: The total failure and death rates are 0.6% and 0.8% higher than based on routine
reporting in northern Vietnam. Although this was a large proportion of treatment failures and
deaths, failure and death rates were low. Defaulting and transfer carry a high risk of failure and in
particular death.
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Background
The global strategy for tuberculosis of the World Health
Organization (WHO), the DOTS strategy, recommends
the use of short-course chemotherapy (SCC). Tuberculo-
sis treatment outcomes are reported according to interna-
tionally accepted definitions [1]. These include cure,
treatment completion, treatment failure, death, default
and transfer-out. Specific criteria are defined for cure,
treatment failure and death. However, patients who did
not complete treatment at the district tuberculosis unit,
i.e. reported as default or transfer-out, may include unde-
tected deaths and treatment failures. The consequence
would be that the overall treatment effectiveness, i.e. the
proportion of patients without death or treatment failure,
would be lower than can be assessed from the routine
reporting of treatment outcomes.
A defaulter is defined as a patient whose treatment was
interrupted for 2 months or more. A transfer-out is
defined as a patient who has been transferred to another
recording and reporting unit and for whom the treatment
outcome is not known [1].
Default and transfer-out rates are low with 2.0% and 1.7%
in the Western Pacific Region [2], but correspond to over
15,700 cases in 2003.
High morbidity and mortality rates are reported after
treatment default, but estimates differ. Mortality after
default was 4% in Singapore [3] and 27% in Mexico [4].
Failure after default was 28% in South Africa [5] and 54%
in the USA [6]. All studies, except the study from Mexico
[4] were carried out in urban settings and follow-up time
differed greatly between studies. Furthermore, as these are
competing risks, the cumulative burden of morbidity and
mortality is unknown. Moreover, no studies have reported
on the bacteriologic and survival status after transfer-out.
Vietnam, one of the 22 high-burden countries for tubercu-
losis [7] report high treatment success rates (92%) of new
smear-positive tuberculosis patients who started treat-
ment in 2002 [7], but with a high relapse and death rate 1
to 2 years after treatment completion [8]. Reported rates
of treatment failure (0.8%) and death (3.4%) were low
[7]. This reported failure rate based on a single smear
examination in routine practice is very low compared to
the failure rate of 5% based on culture at treatment com-
pletion in a clinical controlled trial with an 8-month treat-
ment regimen as is used in Vietnam [9].
We hypothesized that treatment failure and death rates
are higher if these patients are hidden in reported default
or transfer-out. In order to quantify this, we assessed the
proportion treatment failures and deaths based on sur-
vival, the history of re-treatment and sputum smear exam-
ination and culture after 1 to 3 years after treatment
initiation of new smear-positive pulmonary tuberculosis
patients with reported treatment default or transfer-out in
northern Vietnam.
Characteristics of the National Tuberculosis Control Pro-
gramme (NTP) Vietnam are described elsewhere [10].
Treatment outcomes rates were 1.4% for default, 3.0% for
transfer-out, 0.4% for failure and 2.6% for death in north-
ern Vietnam in 2003 [11]. In northern Vietnam in 1996
the prevalence among new smear-positive patients were
17%, 19% and 1.1% for isoniazid, streptomycin and
multidrug resistance, respectively [12]. The HIV preva-
lence was estimated at 0.5% in the adult population in
2005 [13]. The standard NTP treatment regimen for new
patients consists of streptomycin, isoniazid, rifampicin
and pyrazinamide for 2 months, followed by isoniazid
and ethambutol for 6 months, all with daily drug intake
(2SRHZ/6HE).
Methods
The study was conducted in 32 randomly selected NTP
tuberculosis units in 22 provinces in northern Vietnam.
Eligible for inclusion in the cohort in the selected districts
were all patients diagnosed with previously untreated
smear-positive tuberculosis and with a reported treatment
outcome of default or transfer-out and who had started
treatment between 1 January 2002 and 31 December
2003. Excluded were patients ≤15 years and patients liv-
ing outside the district at the time of treatment.
Patient data were recorded on a pre-coded structured
questionnaire. Data on diagnosis, treatment and re-treat-
ment were extracted from routine registers at the district
tuberculosis unit.
The Research board of the National Hospital for Tubercu-
losis and Respiratory Diseases in Hanoi gave scientific and
ethical clearance for this study. Patients who were identi-
fied as smear- or culture-positive at follow-up were offered
tuberculosis re-treatment.
Trained district tuberculosis staff collected the data and
provincial staff and one of the authors (MV) supervised
the study. In November and December 2004 the selected
patients were invited to the district unit. After written
informed consent two sputum samples were collected on
the spot; one before and one after the interview. Patients
who did not report were visited at their homes. If patients
could not be found or had died a non-response interview
was completed with a family member.
Sputum smear microscopy and mycobacterial culture
were performed at two provincial tuberculosis laborato-BMC Public Health 2007, 7:134 http://www.biomedcentral.com/1471-2458/7/134
Page 3 of 8
(page number not for citation purposes)
ries and the National Tuberculosis Reference Laboratory
in Hanoi (NTRL). Sputum specimens were transferred to
the laboratory within 2 days after collection and exam-
ined using the Ziehl-Neelsen method. For each patient a
single mycobacterial culture was performed on Ogawa
medium using the simple decontamination method (i.e.
without centrifugation) [14]. M. tuberculosis was identified
by the niacin test. Drug susceptibility testing (DST) was
done at the NTRL by the proportion method [15]. All neg-
ative slides of patients who had positive cultures and pos-
itive smear slides of patients who had negative cultures
were reread by technicians blinded to the original results.
All smear slides read at one and 20% of slides read at
another provincial laboratory were reread at the NTRL.
A case was defined as smear-positive if at least one sputum
smear examinations was positive. A failure case was
defined as a patient who was smear or culture-positive at
the time of follow-up or had been diagnosed with smear-
positive tuberculosis and started re-treatment at the dis-
trict tuberculosis unit in the interval between start of ini-
tial treatment and time of follow-up.
Data analysis
Data were double-entered using Epi Info 2002. Inconsist-
encies were checked against raw data. Analyses were per-
formed using SPSS 11.5 (SPSS Inc, USA) and Stata/SE
V8.0 (Stata Corp., College Station TX, USA).
The proportion undetected failures was calculated as the
proportion bacteriologically confirmed tuberculosis
among patients with default or transfer-out times the pro-
portion of patients with default (1.4%) or transfer-out
(3.0%) in northern Vietnam in 2003 [11]. Death during
tuberculosis treatment is internationally defined as a
patient who dies for any reason during the course of treat-
ment [1] which is 8 months in Vietnam. Therefore, we
analyzed the proportion of deaths within 8 months after
treatment initiation. Thus, death rates in this study could
be compared to death rates as reported by the NTP. The
proportion undetected deaths within 8 months after treat-
ment initiation was calculated as the proportion death
among patients with treatment default or transferred out
times the proportion of patients with treatment default
(1.4%) or transfer-out (3.0%) patients in northern Viet-
nam in 2003 [11].
To assess differences at the 5% significance level two-sided
Fisher's exact test and Chi2 test with likelihood ratios were
used. Survival curves up were constructed using the Kap-
lan-Meier method.
Results
Included in the cohort were 42 patients with treatment
default and 85 patients with transfer-out. Time of default
or transfer-out was within the first 2 months of treatment
(initial phase) for 10 (24%) of all patients with default
and for 47 (57%) of all patients with transfer-out. Follow-
up sputum smear result at 2 months after treatment initi-
ation was known for 25 patients with default and 25
patients with transfer-out. Of these, 0 (0%) patients with
default and 2 (8%) patients with transfer-out were spu-
tum smear-positive.
No information was available of 41 (32%) patients (Fig-
ure 1); of these 17 (35%) had moved and 6 (13%) were
released from prison (Table 1). The time interval between
treatment initiation and the date the patient was last seen
at the district tuberculosis unit was available for 24
patients with non-response (59%). The median interval
was 5 months (inter-quartile range (IQR) 2 to 21
months).
Twenty-eight patients had died (22%). Fifty-eight patients
were available for follow-up (46%) and all had interview
data and smear results (Figure 1). The median time inter-
val between treatment initiation and follow-up was 22
months (IQR 16 to 29 months).
Interview data showed that of patients with transfer-out
one had been transferred to the commune health center,
one to the district health center, 15 (44%) to the provin-
Study outcomes at time of follow-up of tuberculosis patients  with treatment default or transfer-out Figure 1
Study outcomes at time of follow-up of tuberculosis patients 
with treatment default or transfer-out. sm = smear. C = cul-
ture. Ccont = contaminated culture. * = according to the lab-
oratory and treatment register of the district where the 
patient was initially treated.
Enrollment of patients
127 
Default 
42 
Transfer-out 
85 
Not 
found
32 
Died
19 
Available for
follow-up 
34 (40%) 
Laboratory 
results 
34 (40%) 
Not started 
re-treatment
32* 
Smear-positive 
on re-treatment
2 
Sm-/C+  1
Sm-/C-   1
Sm+/C+     4
Sm+/C-      2
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Sm-/Ccont.2
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cial tuberculosis treatment center and nine to a national
tuberculosis referral hospital. One had not been trans-
ferred and for 7 this remained unknown.
At the time of follow-up 10 of 86 patients with known
study outcomes (11%, 95%CI 5.7–20%) had positive
sputum smears or cultures (Figure 1). Six patients who
had not been re-treated by time of follow-up were smear-
positive and an additional three were culture-positive
(Figure 1). Two patients had started re-treatment for
smear-positive tuberculosis between interrupting initial
treatment and follow-up; one of these patients was cul-
ture-positive at time of follow-up. In addition, two
patients with default stated in the interview to have
received re-treatment, but sputum smear status was
unknown. Therefore, 11 (13%, 95%CI 6.6–22%) patients
in total had bacteriologically confirmed tuberculosis dur-
ing time of follow-up. Of these, all but one patient were
transfer-out and the proportion failure among them did
not differ significantly by age group, sex or area (Table 2).
Drug resistance results could be obtained for seven of
eight positive cultures. Of these, three were multidrug
resistant (Table 3).
Death was recorded for 28 of 86 patients with known
study outcomes (33%, 95%CI 23–44%). Among 27
deceased patients the median time interval from treat-
ment initiation to death was 8 months (IQR 5 to 11
months); for 1 patient this remained unknown. Fifteen
(17% of all patients with known study outcomes, 95%CI
10–27%) patients had died within 8 months after treat-
ment initiation (Table 2 and Figure 2). The proportion
death within 8 months after treatment initiation did not
differ significantly by age group, sex or area (Table 2).
Reported causes of death were tuberculosis for 11, lung
disease for 6 patients, HIV/AIDS for 3, other for 4 and
unknown for 4. Mortality increased with age among
patients with default, but did not differ significantly for
patients with transfer-out (Table 2).
Death or bacteriologically confirmed tuberculosis was
recorded for 39 patients (45%, 95%CI 35–56%) during
the total follow-up time. This was recorded for 29/53
(55%, 95%CI 40–68%) patients with transfer-out and 10/
33 (30%, 95%CI 16–49%) patients with default.
Undetected treatment failures were observed among 0.6%
of patients who started treatment and hidden in default or
transfer-out. This is 60% of all treatment failures, i.e. of
treatment failures among patients with default or transfer-
out plus the treatment failures routinely reported by the
NTP in northern Vietnam (0.4%) (Figure 3). Undetected
death within 8 months after treatment initiation were
observed among 0.8% of patients who started treatment
and hidden in default or transfer-out. This is 24% of all
deaths, i.e. of deaths among patients with default or trans-
fer-out plus the deaths routinely reported by the NTP in
northern Vietnam (2.6%) (Figure 3).
Table 1: Characteristics of non-responders at time of follow-up of tuberculosis patients with treatment default or transfer-out.
Default Transfer out
Non-response
n (% of all in subgroup)
p† Non-response
n (%)
p†
All 9 (21%) 32 (38%)
Age, years 0.20 0.42
15–34 6 (35%) 9 (50%)
35–54 1 (13%) 12 (38%)
≥55 2 (12%) 11 (31%)
Sex 0.46 0.49
Men 6 (27%) 22 (41%)
Women 3 (15%) 10 (32%)
Area 0.81 0.61
Urban 3 (20%) 9 (45%)
Mountainous/remote 2 (17%) 7 (30%)
Rural 4 (27%) 16 (38%)
Reason for non-response
Moved 61 1
Released from prison 0 6*
Never lived here 0 1
Other 10
Unknown 2 14
* of whom 2 with HIV-infection
† P-values based on difference between patients with non-response and patients who had died or were available for follow-up.BMC Public Health 2007, 7:134 http://www.biomedcentral.com/1471-2458/7/134
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Discussion
Of new-smear positive tuberculosis patients with default
or transferred to other tuberculosis units, 45% had died or
had bacteriologically confirmed tuberculosis after 1–3
years follow-up in northern Vietnam in 2003. Sixty per-
cent of treatment failures and 24% of deaths within 8
months after treatment initiation remained undetected
and therefore were unreported in the routine reporting
system. Consequently, the total failure and death rate
were 1.0% and 3.4%.
Eleven patients (13%) had sustained or developed bacte-
riologically confirmed tuberculosis during the follow-up
period. This is similar to the 10% combined failure and
relapse rate observed in a randomized-controlled trial
without rifampicin in the continuation phase [9]. How-
ever, this 13% was lower than in South Africa where 28%
of defaulters had recurrent tuberculosis as diagnosed
through passive case finding [5] and lower than in the
USA where 54% patients with default had a positive cul-
ture within 1 month of the last recorded dose [6]. Possible
explanations for this relatively low failure rate in Vietnam
may be longer treatment duration with better treatment
compliance before default, or a higher proportion of
patients with tuberculosis had died.
With 33%, mortality after treatment default or transfer-
out was high. This was similar to 27% deaths due to tuber-
culosis in Mexico [4] during a 2.3 year follow-up period
after diagnosis. However, the high mortality in our study
may only in part be attributable to tuberculosis, since the
reported cause of death was tuberculosis for only 11 (of
28) patients. However, the cause of death as reported by
family members is probably not accurate and death attrib-
uted to tuberculosis can be under- or overestimated.
Another explanation for the high mortality observed is the
emerging HIV epidemic in Vietnam [16]. Vietnam has no
routine system of HIV testing of tuberculosis patients, and
the HIV-status of the patients in our study was largely
unknown. In the current situation in Vietnam, HIV
Table 3: Tuberculosis drug susceptibility of patients with treatment default (n = 1) or transfer-out (n = 7) and with positive M. 
tuberculosis cultures at follow-up.
Default
n
Transfer-out
n
Fully susceptible 1 1
Resistant to
H0 2
HRS 0 1
HRES 0 2†
No information 0 1
S = Streptomycin, H = Isoniazid, R = Rifampicin, E = Ethambutol
† including 1 patient on re-treatment regimen
Table 2: Failure and death at time of follow-up of tuberculosis patients with treatment default or transfer-out.
Default Transfer-out Total
Death Total* Failure Total† Death Total* Death = 8 months 
after treatment 
initiation
Total*
n (%) n p n (%) n p n (%) np n n p
All 9 (27%, 95%CI
13–46%)
33 10 (29%, 95%CI
15–47%)
34 19 (36%, 95%CI
23–50%)
53 15 (17%, 95%CI 10–
27%)
86
Age, years 0.002 0.85 0.74 0.100
15–34 0 (0%) 11 2 (33%) 5 4 (44%) 9 1 (5%) 20
35–54 1 (14%) 7 4 (29%) 14 6 (30%) 20 4 (15%) 27
≥55 8 (53%) 15 4 (27%) 15 9 (37%) 24 10 (26%) 39
Sex 0.78 1.0 1.0 1.00
Men 4 (25%) 16 6 (29%) 21 11 (34%) 32 8 (17%) 48
Women 5 (29%) 17 4 (31%) 13 8 (38%) 21 7 (18%) 38
Area 0.019 0.47 0.32 0.074
Urban 1 (8%) 12 3 (43%) 7 4 (36%) 11 1 (4%) 23
Mountainous/
remote
6 (60%) 10 3 (37%) 8 8 (50%) 16 7 (27%) 26
Rural 2 (18%) 11 4 (21%) 19 7 (27%) 26 7 (19%) 37
* total = number of deaths & number with known survival
† total = number of patients who did not have bacteriologically confirmed tuberculosisBMC Public Health 2007, 7:134 http://www.biomedcentral.com/1471-2458/7/134
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infected patients are likely to be transferred to provincial
or national hospitals, since the district tuberculosis unit
may not be able to provide adequate health care. HIV
prevalence may therefore be higher among patients
reported as transfer-out compared to patients with
reported treatment success. Furthermore, it is unknown
how many deaths could have been prevented if treatment
was continued in time. In this study 24 of 42 patients who
defaulted were available for a follow-up health examina-
tion. Therefore, active follow-up of patients who did not
complete treatment may be an effective intervention to
ensure treatment completion and thereby lower the high
morbidity and mortality.
A study limitation is the large proportion of patients for
whom the status at follow-up remained unknown. If all
these patients were alive at the time of follow-up and
either none or all had bacteriologically confirmed tuber-
culosis, the failure rate would be either 9% or 41%. There-
fore, the total failure rate is estimated to be 0.4% to 1.8%
higher than based on routine reporting. If all non-
responders were either alive or had died at time of follow-
up, the death rate would be either 22% or 54%. Therefore
the total death rate is estimated to be 0.5% to 1.3% higher
than based on routine reporting. These lower and upper
estimates confirm the finding that a large proportion of
failure and deaths remain undetected among patients
with default or transfer-out.
Another study limitation is the use of the simple method
for culture [17], which may have resulted in 5–10% nega-
tive cultures, especially when bacillary load is low. Conse-
quently, one or two additional culture positive cases are
expected, but that would increase the number of failure
cases only slightly. In contrast, some bacteriologically
confirmed tuberculosis cases may in fact be due to reinfec-
tion rather than treatment failure [18]. Reinfection
occurred among 11% of defaulters in South Africa, but
here the estimated tuberculosis incidence is substantially
higher than in Vietnam [5]. Therefore we conclude that
around 13% of patients with default or transfer-out were
treatment failures.
A large proportion of treatment failures remain currently
undetected by the NTP and those patients are not detected
for further tuberculosis treatment. In this study only two
of eleven patients had started re-treatment. In northern
Vietnam in 2003 this would be 105 undetected failure
cases as compared to 48 cases who received re-treatment
after failure. Moreover, in this study 3 of 7 (43%) patients
carried multidrug resistant strains of those with culture-
positive tuberculosis. Patients with primary multidrug
resistance have a high risk of death and failure with the
standard NTP treatment regimen [19]. These patients may
Proportion failures and deaths during treatment duration  among tuberculosis patients with treatment default or trans- fer-out Figure 3
Proportion failures and deaths during treatment duration 
among tuberculosis patients with treatment default or trans-
fer-out.
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not recover during treatment and may be transferred for
more adequate health care or a place to die. Therefore,
multidrug resistance may explain the high combined fail-
ure and death rate of 55% among patients with transfer-
out. As routinely reported failure cases, these undetected
failure cases are likely to contribute to continued trans-
mission of drug resistant tuberculosis.
Failure and death rates among patients with transfer-out
may reflect that of patients with default or with completed
treatment. This depends on whether patients with trans-
fer-out continued and completed treatment in another
NTP treatment center. This information will guide the
NTP how to lower the high risk of death and failure.
Therefore, it is recommended to evaluate the actual treat-
ment outcome of patients registered with transfer-out at
the provincial and national level. Forty-four percent of
patients reported to be transferred from the district tuber-
culosis unit to the provincial hospital. As a consequence,
a specific treatment outcome, i.e. cure, treatment comple-
tion, death or failure, can be given for around half of the
number of patients with transfer-out.
These findings may be important beyond Vietnam to
countries with a similar tuberculosis epidemiology and
reported treatment outcomes, like many countries in
Southeast Asia [2]. A follow-up study among patients who
did not complete treatment may be considered in settings
with high default or transfer-out rates, such as in Eastern
Europe, or among patients who started treatment in insti-
tution other than ambulatory settings, such as hospitals or
prisons.
Conclusion
Tuberculosis patients with treatment default or transfer-
out carry a high risk of failure and in particular death. Of
tuberculosis patients with treatment default or transfer-
out 13% were actually treatment failures and 17% were
actual deaths within 8 months after treatment initiation in
northern Vietnam. Therefore, in this setting the total treat-
ment failure and death rates are 60% and 24% higher
than based on routine reporting (0.4% and 2.6%).
Although treatment failure and death rates are low, a large
proportion of treatment failures and deaths remain unde-
tected. This is of importance, since undetected failure
cases are likely to contribute to continued transmission of
drug resistant tuberculosis.
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